Tempus ai ceo He is the founder and CEO of Tempus AI, [3] and the co-founder of Groupon, [4] Echo Global Logistics (ECHO), InnerWorkings (INWK), and Mediaocean. Dec 11, 2024 · (Tempus owns 20% of Pathos, and they share data and a C-suite executive. (NASDAQ: TEM), ha vendido una parte significativa de sus acciones en la empresa, según un reciente informe de la SEC. (NASDAQ:TEM), recently sold a significant portion of his holdings, totaling approximately $62 million in value. Mar 3, 2025 · Tempus AI CEO sells $190. • Nov 4, 2024 · CHICAGO, November 4, 2024 — Tempus AI, Inc. Following the sale, the chief executive officer now owns 9,457,283 shares in the company, valued at approximately $481,659,423. Valued at $8. This means that Lefkofsky has been leading Tempus AI for over eight years, driving its mission to leverage artificial intelligence Feb 28, 2025 · Tempus AI’s CEO Eric Lefkofsky, recently sold shares worth over $190. Dec 14, 2024 · ARK Invest CEO Cathie Wood has boldly sought tech stocks that could have a “disruptive” future impact, even if the stock is unprofitable. 2% Feb 21, 2025 · Eric Lefkofsky, CEO y Presidente de Tempus AI , Inc. TEM. und 20. Jan 14, 2025 · AI medicine company Tempus released a peak at its 2024 financials during yesterday's J. A live webcast of the conversation will be available here. Eric Lefkofsky, Tempus' founder and CEO, highlighted Olivia as a key step in Dec 14, 2024 · ARK Invest CEO Cathie Wood has boldly sought tech stocks that could have a “disruptive” future impact, even if the stock is unprofitable. Lefkofsky’s approach to business is as unconventional as it is relentless. CONSOLIDATED BALANCE SHEETS (in thousands, except share and per share amounts) December 31, 2024 December 31, 2023 Assets Current Assets Eric Lefkofsky is the founder and CEO of Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. 증권거래위원회(SEC) 제출 자료에 따르면, 레프코프스키는 2025년 2월 5일부터 7일까지 3일간 총 238,082주의 Class A 보통주를 매각했다. December 31, 2023. (NASDAQ: TEM), sold a significant portion of his holdings in the company according to a recent SEC filing. 13, 2025-- Tempus AI, Inc. 32. View Tempus AI, Inc. ，总部位于美国伊利诺伊州芝加哥，全职雇员2300人，是一家通过人工智能在医疗保健领域的实际应用推进精准医疗的科技公司。 Feb 28, 2025 · Tempus AI (TEM) CEO’su ve Yönetim Kurulu Başkanı Eric P. Following the transaction, the chief executive officer now owns 5,771,787 shares in the company, valued at approximately $308,155,707. 84, for a total value of $23,734,256. 3, 2025-- Tempus AI, Inc. The transactions occurred on December 18, 2024 Eric Lefkofsky is the founder and CEO of Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. 871 aandelen Class A gewone aandelen, met een waarde van ongeveer $ 11,97 miljoen. En la presentación de su oferta pública inicial (OPI), la compañía con sede en Chicago señaló que su objetivo es llevar la medicina a un nuevo nivel mediante la creación de diagnósticos inteligentes que contarán con la aplicación de inteligencia artificial. Laut einer Mitteilung an die US May 30, 2024 · Tempus is also trying to position itself as an AI company even though AI revenue accounted for only $5. This acquisition will likely help Tempus revolutionize healthcare Eric Lefkofsky, CEO and Chairman of Tempus AI , Inc. 56. US) on CEO. ) Masayoshi Son, chairman and CEO of SoftBank (center) shakes hands with Tempus AI COO Ryan Fukushima (left) while Lefkofsky joins on screen. 20. Jun 1, 2023 · AI-enabled clinical assistant provides access to patient insights directly at your fingertips. (NASDAQ: TEM)의 CEO이자 회장인 에릭 레프코프스키가 최근 자사 주식의 상당 부분을 매각했다. After hitting a high of $91. 12. On January 22, Lefkofsky sold 2 days ago · 网页链接{tempus AI CEO Eric Lefkofsky sells $16. Feb 28, 2025 · Tempus - AI-based precision medicine solutions for oncology. 財務表から読み解く企業価値 Tempus AIは、2024年第3四半期に力強い成長を示した。売上高は前年同期比33%増の1億8090万ドルに達し、特に Jan 22, 2025 · Tempus AI’s strategic moves and groundbreaking technological applications mark it as a key player in the future of precision medicine, blending AI and data analytics to reshape healthcare delivery. 4M in common stock. According to a filing with the Securities and Eric Lefkofsky, CEO and Chairman of Tempus AI , Inc. 39, for a total transaction of $4,580,221. ET. Feb 7, 2025 · Eric P. (NASDAQ: TEM), ha recentemente venduto una parte significativa delle sue partecipazioni nella società. Feb 25, 2025 · Despite filing a fourth-quarter and year-end 2024 earnings report that the CEO described as "fantastic" yesterday afternoon, Tempus AI shares fell overnight and a major investment house downgraded Apr 26, 2024 · Tempus AI, Inc. The trade was Jan 21, 2025 · Tempus AI, Inc. (NASDAQ: TEM), heeft volgens een recente SEC-melding een aanzienlijk deel van zijn belang in het bedrijf verkocht. 02, for a total transaction of $5,948,058. [3] It was established by Lefkofsky soon after his wife was diagnosed with breast cancer . View Eric Feb 27, 2025 · The corporate mailing address for Mr. Key takeaways, CEO insights, and revenue outlook – read now! Jan 21, 2025 · Insider Transactions at Tempus AI. (TEM) stock's management team. Lefkofsky sold 187,655 shares of the firm's stock in a transaction dated Wednesday, December 18th. Jul 8, 2021 · Tempus, a leader in artificial intelligence and precision medicine, today announced the addition of six new hires to the leadership team, including a new Chief Commercial Officer, Chief Financial Officer, General Counsel, and the company’s first Chief Accounting Officer, Senior Vice President of Marketing, and Senior Vice President of Corporate Development. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has completed its acquisition of Ambry Genetics, a recognized leader in genetic testing that aims to improve health by understanding the relationship between genetics and disease. Feb 21, 2025 · Eric Lefkofsky, CEO und Vorsitzender von Tempus AI , Inc. 4M in common stock; Cathie Wood Loads Up on Tempus AI Stock (TEM) Tempus AI Reports Strong Growth in 2024 Earnings; SHARE THIS POST. Am Mittwoch ging es dann letztlich um weitere 5,9 Prozent auf 50,45 US-Dollar nach oben. CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. The company also announced that it has entered into an agreement to acquire Ambry Genetics, a Feb 25, 2025 · This afternoon, Tempus released results for the quarter and the year ended December 31, 2024. 75. Following the completion of the sale, the chief executive officer now owns 4,895,589 shares of the company's stock, valued at Nov 9, 2024 · 🚀 AI-powered summary of Tempus AI, Inc. Now, as AI becomes increasingly integrated into healthcare, tools like olivia will be essential in helping patients understand and navigate their care,” said Eric Lefkofsky, Founder and CEO of Tempus. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today reported financial results for the quarter that ended September 30, 2024. Feb 27, 2025 · Eric Lefkofsky, CEO and Chairman of Tempus AI , Inc. Feb 14, 2025 · Tempus AI, Inc. The company’s quarterly earnings will be released the same day. [ 4 ] Dec 31, 2024 · CHICAGO --(BUSINESS WIRE)--Jan. 49%) 3/7/2025 Disclaimer. 4, 2024, to acquire Ambry Genetics for $600 million. CHICAGO—Eric Lefkofsky, CEO and Chairman of Tempus AI , Inc. Following the completion of the transaction, the chief executive officer now owns 5,771,787 shares in the company, valued at In a regulatory filing on Friday, Tempus AI disclosed that Chairman and CEO Eric Lefkofsky sold a series of shares beginning on January 22, totaling about $62M. 4, 2024-- Tempus AI, Inc. Tempus AI CEO sells $190. 93, for a total transaction of $28,640,230. “As revenues have been growing quickly, we’re not investing all that gross profit dollar growth back into the business. Lefkofsky, bu hafta güçlü bir insider satışı gerçekleştirdi. Jan 23, 2025 · Shares of Tempus AI are down 92c, or 2%, to $49. 2025 8:50pm ET Tempus AI CEO sells $190. Nancy Pelosi steigt bei Tempus AI ein. Full Year 2024 Select, Preliminary, Unaudited Financial Results Revenue of approximately $693 million, representing approximately 30% growth year-over Feb 28, 2025 · Tempus AI, Inc. He is also the co-founder of Pathos AI, a clinical stage biotechnology company focused on re-engineering drug development; … Continued Eric Paul Lefkofsky (born September 2, 1969) [2] is an American billionaire businessman. Aug 1, 2024 · AIアプリケーション 役員一覧 松井 健太郎（代表取締役 社長兼CEO） Ryan Fukushima（代表取締役） 柴山 和久（取締役 CDO） Andy Polovin（取締役） Jim Rogers（取締役） 筒井 多圭志（取締役 Chief Scientist） 株主 ソフトバンクグループ株式会社 50% Tempus AI, Inc. The … Continued Nov 4, 2024 · CHICAGO--(BUSINESS WIRE)--Nov. (NASDAQ:TEM), hat laut einer kürzlichen SEC-Meldung einen bedeutenden Teil seiner Unternehmensanteile veräußert. FACEBOOK. 75, for a total value of $190,363,747. 1B. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today reported financial results for the quarter that ended June 30, 2024, and provided recent business highlights. SoftBank invested $200 million into Tempus AI earlier this year and announced a joint venture to bring Tempus’ technology to Japan. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today introduced a suite of new, transformative capabilities available in Tempus One, the company’s generative AI assistant. The Jan 22, 2025 · Damit erlebte die Aktie des Börsenneulings - Tempus AI hatte erst im Juni 2024 seinen Börsenstart gefeiert - ihren bis dato erfolgreichsten Handelstag. Secondo un recente documento SEC, Lefkofsky ha ceduto azioni per un valore di circa $41 milioni nell’arco di due giorni, il 5 e 6 marzo 2025. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a collaboration with Genialis, the RNA-biomarker company. Jun 14, 2024 · Tempus AI founder and CEO Eric Lefkofsky joins 'Squawk Box' to discuss taking the company public on Nasdaq later today, the origin of the company, More for You 25 Celebrities Who Made the Most Dec 11, 2024 · Tempus AI, founded in 2015 by Eric Lefkofsky in Chicago, Illinois, is a health technology company that uses artificial intelligence to advance precision medicine. He is a founding partner of Lightbank , a venture fund investing in disruptive technologies. The shares were sold at an average price of $58. (TEM) Q3 2024 earnings call. The transactions, disclosed in Oct 24, 2024 · No sólo es la primera empresa que Lefkofsky fundó en solitario, sino que también es, con diferencia, donde más tiempo pasó como CEO. On February 19 and 20, Lefkofsky Jan 24, 2025 · Tempus AI, Inc. Eric Lefkofsky, CEO y Presidente de Tempus AI , Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will participate in the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3, 2024, held in New York, New York. 107亿美元，远超5月份向美国证券交易委员会提交申请时的1亿美元募资计划。 4 days ago · Eric Lefkofsky, CEO e Presidente di Tempus AI , Inc. 70. Op 19 en 20 februari verkocht Lefkofsky in totaal 153. Lefkofsky sold 85,788 shares of the business's stock in a transaction that occurred on Friday, January 24th. CONSOLIDATED BALANCE SHEETS (in thousands, except share and per share amounts) December 31, 2024. 21 January 2025 . Jan 25, 2025 · Tempus AI, Inc. Tempus AI can also be reached via phone at 800-976-5448 and via email at [email protected]. This represents a 1. SEC’e yapılan son bildirime göre, Lefkofsky 5 ve 6 Mart 2025 tarihlerinde yaklaşık 41 milyon dolar değerinde hisse sattı. 24, 2025-- Tempus AI, Inc. 이 영상에서는 에릭이 자신의 아내의 암 투병 경험에서 시작된 헬스케어 혁신 과정을 이야기하며, 데이터와 AI를 통한 통합적 접근 방식이 Dec 20, 2024 · Tempus AI, Inc. Learn about Tempus AI, Inc. Start Trading Dec 11, 2024 · Tempus AI, founded in 2015 by Eric Lefkofsky in Chicago, Illinois, is a health technology company that uses artificial intelligence to advance precision medicine. Feb 24, 2025 · Tempus AI, Inc. With access to over 50 petabytes of de-identified multimodal data, Tempus is … Continued Feb 5, 2025 · Insider Trading: Tempus AI Stock (TEM) Down after CEO Sells Shares Worth Over $190M. All thanks to an earnings miss and news that CEO Jim Rogers sold 31,000 shares. The stock was sold at an average price of $49. 8, 2025-- Tempus AI, Inc. Tempus CEO Eric Lefkofsky told investors on a Monday earnings call that Tempus currently offers hereditary testing and it’s one of the company’s main product categories. Following these transactions, Lefkofsky directly owns 5,293… 5 days ago · Tempus AI, Inc. He is a founding partner of Lightbank, a venture fund investing in disruptive technologies. In related news, CEO Eric P. 36 million. AI & ML in action: Unlocking RWD with GenAI through Tempus LensTuesday, March 25, 2025 11 AM PT / 1 PM CT / 2 PM ET Eric Lefkofsky is the founder and CEO at Tempus, a leader in artificial intelligence and precision medicine. Dabei profitiert der Anteilschein gleich an mehreren Fronten. Eric Lefkofsky, a challenge that led to the birth of Tempus, a company that’s impossible to ignore. ソフトバンクグループ株式会社（代表取締役 会長兼社長執行役員：孫 正義、英文社名：SoftBank Group Corp. Jan 22, 2025 · Tempus AI’s strategic moves and groundbreaking technological applications mark it as a key player in the future of precision I'm the CEO of a Company Generating $1. Lefkofsky sold 187,655 shares of the business's stock in a transaction on Wednesday, December 18th. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the national launch of olivia. and Lightbank Investments 1B, LLC. See the full leadership team at Craft. Following the completion of the sale, the chief executive officer now owns 6,502,643 shares in the company, valued at $324,091,727. Tempus AI’s strategic moves and groundbreaking Feb 14, 2025 · Tempus AI, Inc. Experience Tempus Lens in action, with an exclusive live demonstration of our newest AI advancements, and hear perspectives on AI's expanding role in healthcare and its transformative potential. Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. (NASDAQ: TEM), recently sold a significant portion of his holdings in the company. Assets Current Assets Jan 14, 2025 · Tempus AI, Inc. Nancy Pelosi steigt bei Tempus AI ein Mar 21, 2022 · Tempus, a leader in artificial intelligence and precision medicine, today announced the launch of Edge, an innovative platform that allows pathologists to access developing AI models intended to identify specimens with potentially actionable biomarkers using a single hematoxylin and eosin stain (H&E) slide. Founder and CEO of Tempus. The multi-year agreement allows Genialis to leverage Tempus’ multimodal dataset to develop new RNA Feb 3, 2025 · CHICAGO, February 03, 2025--Tempus AI, Inc. 4 million—a 30% year-on-year increase. CHICAGO, August 6, 2024 — Tempus AI, Inc. Feb 24, 2025 · Kevin Thompson, CEO of 9i Capital Group, explains that increased institutional ownership and strong investor sentiment toward AI-related stocks have contributed to Tempus AI's remarkable performance. Jun 14, 2024 · Lefkofsky, the founder and CEO of Tempus, spoke with Forbes about the IPO and the company, which is built on a massive trove of AI-trained patient and genomic data. Class A TEM stock quote prices, financial information, real-time forecasts, and company news from CNN. TipRanks 6d. About Tempus. Nov 4, 2024 · Ambry Genetics has entered into a definitive agreement to be acquired by Tempus AI, a company advancing precision medicine through the practical application of artificial intelligence in healthcare. (TEM. As the founder, he has held the position of CEO since its inception. 05. Following the sale, the chief executive officer now directly owns 9,557,283 shares of the company's stock, valued at $358,780,403. (NASDAQ: TEM), ha vendido recientemente una parte significativa de sus acciones, por un valor total de aproximadamente 62 millones de dólares Nov 6, 2024 · Tempus also expects the acquisition to expand the company into new disease categories including pediatrics, rare disease, immunology, reproductive health and cardiology. The goal of this collaboration is to more precisely gather insights that will inform novel drug discovery and development … Continued Feb 26, 2025 · It’s been a rocky few days for Tempus AI (). On January 22, Lefkofsky sold a Tempus AI's Founder & CEO is Eric Lefkofsky. Following the sale, the chief executive officer now owns 5,458,502 shares in the company, valued at $368,612,640. 4M in common stock by Tempus AI, Inc. He points out that insider selling at higher price levels could signal a potential peak in the stock's trajectory. (NASDAQ:TEM - Get Free Report) CEO Eric P. (NASDAQ: TEM), recently sold a significant portion of his holdings, totaling approximately $62 million in value. 64. Tempus AI is a technology company focused on leveraging artificial intelligence and data-driven Feb 18, 2025 · Tempus AI (NASDAQ: TEM) ha anunciado su participación en la próxima Conferencia de Tecnología, Medios y Telecomunicaciones de Morgan Stanley, programada del 3 al 6 de marzo de 2025, en San Francisco, CA. Lefkofsky and other Tempus AI executives is 600 WEST CHICAGO AVENUE SUITE 510, CHICAGO IL, 60654. The trade Feb 21, 2025 · Eric Lefkofsky, CEO and Chairman of Tempus AI , Inc. Following the completion of the sale, the chief executive officer now owns 5,293,005 shares of the company's stock, valued at approximately $357,436,627. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has . (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced select, preliminary, unaudited results for the fourth quarter and full year ended December 31, 2024. 14. Aug 6, 2024 · Tempus Reports Second Quarter 2024 Results . Year-over-year revenue growth accelerated to 35. 98, totaling $16,236,578. Learn More on Eric P. The transactions, disclosed in Tempus AI founder and CEO Eric Lefkofsky joins 'Squawk Box' to discuss taking the company public on Nasdaq later today, the origin of the company, Feb 7, 2025 · CHICAGO—Eric Lefkofsky, CEO en voorzitter van Tempus AI , Inc. olivia is an AI-enabled personal health concierge app designed to empower patients by bringing their health-related data into one central location and leveraging advanced AI to provide actionable … Continued Jan 13, 2025 · Tempus AI, Inc. 7 Billion Annual Revenue. The company also announced that it has entered into an agreement to acquire Ambry Genetics, a leader in genetic … Continued Nov 25, 2024 · Shares of Tempus AI TEM gained 18. “In the last year, … Continued Jun 14, 2024 · Tempus AI apuesta por ser el futuro en la medicina. operates as a healthcare technology company. 19. Before founding Tempus, Mr. TEM now represents 3. Feb 25, 2025 · Loop Capital raised the firm’s price target on Tempus AI (TEM) to $74 from $52 and keeps a Buy rating on the shares. “This acquisition complements our strategy of … Continued Founder & CEO . 082 aandelen Class A Common Stock over drie dagen, van 5 tot 7 februari 2025. On January 22, Lefkofsky sold a series of shares at prices ranging from $47. Lefkofsky sold 476,209 shares of the company's stock in a transaction dated Wednesday, January 22nd. Comprehensive performance, salary and tenure analysis for the CEO, board and leadership team. His sale included a grand total of 1,207,065 Tempus AI shares worth approximately $62 million. Lefkofsky sold 84,948 shares of the firm's stock in a transaction on Wednesday, February 12th. 39, for a total value of $4,580,221. 53 in Thursday morning trading after it was disclosed in a regulatory filing last night that founder and CEO Eric Lefkofsky disposed of 946,084 4 days ago · Tempus AI, Inc. The company will hold the third quarter 2024 earnings conference call at 4:30 p. 2024年6月，人工智能精准医疗公司Tempus AI（简称“Tempus”）在纳斯达克上市，IPO募资4. The stock was sold at an average price of $67. 93. Morgan Healthcare Conference, saying its revenue of about $693 million showed 30% growth year over year Feb 12, 2025 · Over the last 12 months, 11 insiders sold some of their Tempus AI shares. 06. TipRanks 8d. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced they will report financial results for the third quarter on Monday, November 4, 2024. 41 to $68. Share Interview. The shares were sold at an average price of $67. Tempus Founder and CEO, Eric Lefkofsky, will speak in a fireside discussion at the conference … Continued Feb 21, 2025 · Eric Lefkofsky, CEO en voorzitter van Tempus AI , Inc. Real-time discussion about Tempus AI, Inc. All in all, the CEO executed 15 sell transactions, at prices ranging from $47. 5 days ago · Morgan Stanley raised the firm’s price target on Tempus AI to $60 from $50 and keeps an Overweight rating on the shares. Morgan Healthcare Conference, saying its revenue of about $693 million showed 30% growth year over year Jan 22, 2025 · Eric Lefkofsky, Tempus’ founder and CEO, highlighted Olivia as a key step in empowering patients to take control of their health journeys. Collectively, insiders among which are the company’s CEO and CFO sold a total of around $278. Lefkofsky sold 85,788 shares of the business's stock in a transaction dated Friday, January 24th. The stock was sold at an average price of $53. 53, for a total transaction of $5,428,601. Lefkofsky sold 74,485 shares of Tempus AI stock in a transaction on Wednesday, February 5th. Lefkofsky sold 80,388 shares of the stock in a transaction dated Friday, February 7th. 54, for a total value of $7,044,568. Eric Lefkofsky is our Founder and has served as our Chief Executive Officer and a member of our board of directors since our inception. 49. (NASDAQ: TEM), heeft onlangs een aanzienlijk deel van zijn aandelen in het bedrijf verkocht. Founded by Eric Lefkofsky in the year 2015. (NASDAQ:TEM), recently sold shares worth approximately $7,045,334, according to an SEC filing. Tempus AI . Los días 19 y 20 de Jan 22, 2025 · Eric Lefkofsky, Tempus’ founder and CEO, highlighted Olivia as a key step in empowering patients to take control of their health journeys. The stock was sold at an average price of $37. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced select, preliminary, unaudited results for the fourth quarter and full year ended December 31, 2024 . CA, an investment chat community for Canada's small cap markets Feb 3, 2025 · Tempus AI (NASDAQ: TEM) has completed its acquisition of Ambry Genetics, a genetic testing company focused on understanding genetics-disease relationships. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4th, held in New York, NY. According to a filing with the Securities and Nov 7, 2024 · Tempus的商业模式跑通之后，奋力押注人工智能领域的软银也希望再复制一个Tempus。 今年6月，软银集团CEO孙正义宣布与Tempus AI达成合作，将在日本 Jan 24, 2025 · Eric Lefkofsky, CEO and Chairman of Tempus AI , Inc. COPY LINK. Lefkofsky sold 562,345 shares of the stock in a transaction that occurred on Wednesday, March 5th. Jan 27, 2025 · In a regulatory filing on Friday, Tempus AI disclosed that Chairman and CEO Eric Lefkofsky sold a series of shares beginning on January 22, totaling about $62M. P. Public Company. 05B over 8 rounds from 11 investors. TWITTER. · Location: Greater Chicago Area · 500+ connections on LinkedIn. Lefkofsky, CEO and Chairman of Tempus AI, sold 239,982 shares of Class A Common Stock across multiple transactions on February 5th, 6th, and 7th, 2025, at weighted average prices ranging from $66. 10. 0. Jun 14, 2024 · Tempus AI founder and CEO Eric Lefkofsky joins 'Squawk Box' to discuss taking the company public on Nasdaq later today, the origin of the company, More for You Kamala Harris Could Break 32-Year Tempus AI , Inc. Feb 18, 2025 · Tempus Founder and CEO, Eric Lefkofsky, will participate in a fireside discussion at the conference on Monday, March 3, 2025. The shares were sold at an average price of $50. (NASDAQ: TEM), heeft onlangs een aanzienlijk deel van zijn aandelenpakket in het bedrijf verkocht. 3 days ago · Tempus AI also just released its Q4 2024 earnings and the highlights include: Annual revenue of $693. Am 19. Eric Lefkofsky, CEO and Chairman of Tempus AI , Inc. Feb 5, 2025 · Since then, Tempus AI has rapidly ascended within Ark’s portfolio, becoming the tenth-largest holding in the flagship Ark Innovation ETF. Eric Lefkofsky, CEO and Chairman of Tempus AI, Inc. [5] Eric Lefkofsky is the founder and CEO at Tempus, a leader in artificial intelligence and… · Experience: Tempus, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has completed its Feb 28, 2025 · Eric Lefkofsky, CEO und Vorsitzender von Tempus AI , Inc. 78 to $54. m. Feb 10, 2025 · Tempus AI, Inc. According to a filing with the Securities and Exchange 4 days ago · Eric Lefkofsky, CEO en voorzitter van Tempus AI , Inc. Letter from Tom Schoenherr, CEO: Definitive Agreement for Acquisition of Ambry Genetics by Tempus AI - Press Release | Ambry Genetics Jan 21, 2025 · “At Tempus, our goal has always been to improve patient outcomes by harnessing the power of data and AI. $381. The shares were sold at an average price of $37. 35 % decrease Jan 14, 2025 · SAN FRANCISCO – Speaking Monday at the JP Morgan Healthcare Conference, Tempus AI CEO and Founder Eric Lefkofsky provided more detail about the company's $600 million acquisition of Ambry Genetics, which he said will allow Tempus to enter new disease areas beyond cancer, augment the firm's data and analytics capabilities, and provide geographic expansion into the West Coast. According to a filing with the Securities and Exchange CHICAGO—Eric Lefkofsky, CEO and Chairman of Tempus AI , Inc. 8% in the fourth quarter of 2024 Feb 24, 2025 · CHICAGO, February 24, 2025 — Tempus AI, Inc. 1 million increase in annual gross profit—33. ）の公式サイトです。当社の理念・ビジョン・戦略、企業情報、株主・投資家（IR）情報、事業セグメント・グループ企業、サステナビリティ（ESG）情報をご覧いただけます。 Shares of Tempus AI Inc. (formerly Tempus Labs [1]) is an American health technology company [2] founded in 2015 by Eric Lefkofsky in Chicago, Illinois. 65 Nov 25, 2024 · 11/25/2024 - 08:30 AM . Raised a total funding of $1. The company analyzes clinical and molecular data to provide personalized treatment options for patients, focusing on areas like oncology, cardiology, and depression. The sales were made indirectly through various entities associated with Lefkofsky, including Innovation Group Investors, L. Available on iOS and Android, Olivia underscores Tempus’ commitment to harnessing AI for better patient outcomes. The trade was a 1. Her ARK funds recently had a significant buy on Tempus AI. 78 to $51. The shares were sold at an average price of $53. 50% Jan 27, 2025 · Lefkofsky’s sale of Pelosi’s AI stock was not preplanned. Joining me today from Tempus are Eric Lefkofsky, Founder and CEO of Tempus; and Jim Rogers, CFO. On February 19 and 20, Lefkofsky Oct 24, 2024 · Tempus AI, Inc. 45, the stock plummeted to a low of $55. Feb 3, 2025 · Tempus AI, Inc. 8% year-over-year in the fourth quarter of 2024 Gross profit growth accelerated to … Continued Oct 17, 2024 · Walking through health technology firm Tempus AI’s midtown Manhattan office, Eric Lefkofsky brushes past stick-straight fronds of snake plants in neatly arranged planter boxes and employees Feb 3, 2025 · CHICAGO--(BUSINESS WIRE)--Feb. Dec 28, 2024 · AIが医療を変える。その最前線に立つTempus AIは、診断と治療の精度を飛躍的に高める革命を起こしている。その成長の鍵とは何か、その全貌を解説する。 1. (Nasdaq:TEM)创立于2015年，前称Tempus Labs, Inc. “This app goes beyond organizing Feb 17, 2025 · “We haven’t yet really figured out how to pay for AI in healthcare,” says Tempus AI CEO Dr. Sep 11, 2024 · Learn how AI and ML tools seamlessly integrate biomarkers into the diagnostic process, ensuring patients receive the right treatment(s) at the right time. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today reported financial results for the quarter and year ended December 31, 2024. Februar Dec 15, 2024 · ARK InvestのCEOであるキャシー・ウッドは、長期的な「破壊的」テクノロジーに着目した投資で知られている。最近、彼女はヘルステクノロジー企業であるTempus AI株を大規模に買い増しした。その背景や企業動向、アナリスト評価をもとに、本記事ではTempus AIの現状を整理する。 Tempus AIとは Tempus AI Aug 28, 2024 · Tempus AI, Inc. Lefkofsky, 27 Şubat’ta gerçekleşen işlemde 190,3 milyon dolar karşılığında 3,2 milyon hisse sattı. Lefkofsky's contact information. Jun 14, 2024 · Tempus AI, Inc. Start Trading Futures Related Stocks. “We are CHICAGO— Tempus AI , Inc. The transaction, valued at $600 million total, consists of $375 million in cash and $225 million in shares, with $100 million subject to a one-year lock-up period. Jan 8, 2025 · CHICAGO--(BUSINESS WIRE)--Jan. Following the transaction, the chief executive officer now directly owns 5,208,057 shares of the company's stock, valued at $364,668,151. Tempus, a leader in artificial intelligence (AI) and precision medicine, today announced the upcoming broad launch of Tempus One – the first, AI-enabled clinical assistant that leverages advancements in generative AI to provide clinicians access to patient insights directly at their fingertips. (NASDAQ: TEM) surged 35% on Tuesday, bringing its market capitalization to $7. The transactions, disclosed in Feb 3, 2025 · Tempus AI, Inc. 24 (0. 53, for a total transaction of $5,029,972. EMAIL. Tempus AI Aktie (NASDAQ: TEM) und aktueller Kurs 48,86 - dazu Charts, News, Termine und Kursziele zu Tempus AI. Revenue growth accelerated to 35. He is the co-founder and General Partner of Lightbank, a private venture capital firm specializing in investments in technology companies. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. Should You Invest $1,000 in Tempus AI Right Now? Before you consider Tempus AI, you'll want to hear this. Lefkofsky sold 3,240,234 shares of the business's stock in a transaction that occurred on Thursday, February 27th. . ）の公式サイトです。当社の理念・ビジョン・戦略、企業情報、株主・投資家（IR）情報、事業セグメント・グループ企業、サステナビリティ（ESG）情報をご覧いただけます。 Jun 14, 2024 · “We’re on a really good trajectory,” Tempus AI CEO Eric Lefkofsky said on CNBC’s “Squawk Box” Friday morning before shares started trading. 82. (NASDAQ: TEM), hat kürzlich einen beträchtlichen Teil seiner Unternehmensanteile veräußert. 5 million of revenue, approximately 1% of total revenue in 2023. 5 billion. in 2008, where he held various roles, including Executive Chairman (through August 2013), Chief Executive Officer (August 2013 to November 2015), and Chairman of the board of directors (November Jan 28, 2025 · In a regulatory filing on Friday, Tempus AI (TEM) disclosed that Chairman and CEO Eric Lefkofsky sold a series of shares beginning on January 22, totaling about $62M. (NASDAQ:TEM), has recently sold a significant portion of his holdings in the company. Register now . 4% after it announced an agreement, on Nov. Other executives include Shane Colley, Chief Technology Officer; Jim Rogers, Chief Financial Officer and 20 others. Tempus One, which initially launched in 2023, provides both physicians and researchers AI-enabled services that leverage generative AI Feb 20, 2025 · Eric Lefkofsky, CEO and Chairman of Tempus AI , Inc. Antes de Tempus, sólo fue realmente CEO de una empresa pública una vez: en Groupon, en un papel interino de co-CEO después de que su junta (que Lefkofsky presidía) despidiera a Andrew Mason. Lefkofsky co-founded Groupon, Inc. 50. 2% of ARKK’s total assets, with a Feb 28, 2023 · Tempus, a leader in artificial intelligence (AI) and precision medicine, today announced a multi-year, strategic collaboration with Pfizer in which the two companies are working together to further AI and machine learning-driven efforts in therapeutic development. 85. 96. Tempus has 37 competitors. This Tempest AI의 상장과 창업자 에릭 라오시의 패션의 여정을 다루는 영상으로, 인공지능 진단 기술의 발전과 건강 관리 시스템의 효율성에 대한 통찰을 제공합니다. Volgens een recente SEC-melding heeft Lefkofsky aandelen ter waarde van ongeveer $ 41 miljoen verkocht gedurende twee dagen, 5 en 6 maart 2025. (NASDAQ: TEM) CEO’su ve Yönetim Kurulu Başkanı Eric Lefkofsky, yakın zamanda şirketteki hisselerinin önemli bir kısmını sattı. The shares were sold at an average price of $70. 71 million worth of shares Jun 14, 2024 · “We’re on a really good trajectory,” Tempus AI CEO Eric Lefkofsky said on CNBC’s “Squawk Box” Friday morning before shares started trading. Q4 results were in-line with mid-January preliminary announcement and FY25 Aug 8, 2024 · “当你有个人愿望想实现、有个人问题想解决时，创业是最好的办法。”——Eric Lefkofsky. 2 million in stock} 网页链接{Insider Trading: Tempus AI Stock (TEM) Down after CEO Sells Shares Worth Over $190M内幕交易：Tempus AI 股票 （TEM） 在 CEO 出售价值超过 $190M 的股票后下跌} 网页链接{Tempus Ai Stock Ownership in 2025Tempus Ai 2025 年的股票所有权} Feb 24, 2025 · CHICAGO--(BUSINESS WIRE)--Feb. Volgens een melding bij de Securities and Exchange Commission verkocht Lefkofsky in totaal 238. When did Eric Lefkofsky join Tempus AI? Eric Lefkofsky founded Tempus AI in January 2015, marking the beginning of his journey with the company. jbtesiy mkuug zkzhe ptdbkh mnehw ufwo boye cktkdv rduq noni kivxe mgpz gkyvfj oumeytn ylech